VIVO  valuation analysis

Basics
Name: Meridian Bioscience Inc
Description: Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2022
Market cap: $1.14B (1204th)
Sales(TTM): $339.29M (1300th)
Earnings(TTM): $62.42M (1093rd)

Value
FFER: 1.15 (why)
Actual price: $25.79
FFEThis is Meridian Bioscience Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $22.48
Quantile: VIVO is expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Meridian Bioscience Inc
"Diagnostics & Research" industry
Sales / MarketCap
Meridian Bioscience Inc
"Diagnostics & Research" industry
Book / MarketCap
Meridian Bioscience Inc
"Diagnostics & Research" industry
Equity / Assets
Meridian Bioscience Inc
"Diagnostics & Research" industry